INVOKANA PATENTS FACING OPPOSITIONS
INVOKANA facing oppositions at the European Patent Office (EPO)
| Patent Number | Title | Applicants | Legal Status | Legal Status Date | Oppositions | Activity Alert |
|---|---|---|---|---|---|---|
| EP2568988B1 | Pharmaceutical formulations comprising 1 - (beta-d-glucopyranosyl) - 2 -thienylmethylbenzene derivatives as inhibitors of sglt | Revoked | Mar 16, 2022 |
LEK PHARMACEUTICALS
| ||
| EP2102224B2 | Crystalline form of 1- (ß-d-glucopyranosyl) -4 -methyl- 3- [5- (4 -fluorophenyl) -2-thienylmethyl]benzene hemihydrate | Patent maintained as amended | Jul 02, 2021 |
GALENICUM HEALTH S.L.
| ||
| EP2896397B2 | Novel compounds having inhibitory activity against sodium-dependant glucose transporter | Patent maintained as amended | Sep 04, 2020 |
GENERICS
GALENICUM HEALTH S.L.
| ||
| EP1651658B2 | Novel compounds having inhibitory activity against sodium-dependant transporter | Patent maintained as amended | Jul 10, 2020 |
GALENICUM HEALTH S.L.
|